Nordisk Company company information, Employees & Contact Information

EU approval makes Novo Nordisk’s oral semaglutide the first GlobeNewswire

EU drugs regulator to allow Novo Nordisk to include heart condition in Ozempic label Reuters

EU clears Novo Nordisk's Rybelsus label for heart benefits FirstWord Pharma

Novo Nordisk stock rises after EU approves heart benefit label for Rybelsus Investing.com

Novo Nordisk’s Rybelsus Becomes First EU Approved Oral GLP-1 Reducing Severe Cardiovascular Events Pharmaceutical Executive

Novo Nordisk Overtakes SAP as Europe’s Most Valuable Company Bloomberg

Novo Nordisk files high-dose Wegovy in EU pharmaphorum

EU approves update for Novo Nordisk’s oral semaglutide in cardio risk reduction The Pharma Letter

Novo Nordisk Is Europe’s Most Valuable Company—Again. Eli Lilly, Watch Out. Barron's

Ozempic giant Novo Nordisk to cut 9,000 jobs politico.eu

EU approval makes Novo Nordisk’s oral semaglutide first and only oral GLP-1 RA to reduce cardiovascular death, heart attack, and stroke PharmaLive

Novo Nordisk gets EU recommendation to update Alhemo label Seeking Alpha

Eli Lilly (LLY) Rival Novo Nordisk’s Stock Pops in Europe on Wegovy Data TipRanks

European stocks close up; Novo Nordisk logs its biggest daily drop on record Reuters

Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities GlobeNewswire

The Most Valuable European Company Is No Longer Novo Nordisk Barron's

Novo's Ozempic linked to rare cases of serious eye disorder, EU regulator says Reuters

Novo Nordisk submits higher Wegovy dose to the European Medicines Agency for approval Reuters

Novo Nordisk regains crown as Europe's most valuable company Reuters

Software maker SAP unseats Novo Nordisk as Europe's largest company Reuters

Novo Holdings' $16.5 bln Catalent buy wins EU antitrust approval Reuters

LVMH dethrones Novo Nordisk as Europe's most valuable company | Fortune Europe Fortune

Novo Nordisk Reclaims Top Spot in Europe by Market Value Insider Monkey

EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal Reuters

Novo Nordisk's Ozempic faces EU review for potential eye disease connection Reuters

Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints Fortune

Europe's largest listed company Novo Nordisk shares advisory for Americans on Ozempic drug that Elon Musk Times of India

SAP leapfrogs Novo Nordisk to become Europe’s most valuable company Financial Times

SAP overtook Novo Nordisk to become Europe's most valuable company Euronews.com

LVMH overtakes Novo Nordisk as Europe’s most valuable company Financial Times

Novo Nordisk is no longer Europe's most valuable company medwatch.com

SAP surpasses Novo Nordisk to become Europe's most valuable company TechSpot

Europe: Stocks close up; Novo Nordisk logs its biggest daily drop on record The Business Times

Novo Nordisk secures EMA approval for Rybelsus label update Pharmaceutical Technology

Did Novo open the Canadian market to GLP-1 generics? Labiotech.eu

Novo Nordisk's Wegovy wins EU backing for reducing heart risks CNBC

SAP Overtakes Novo Nordisk to Become Europe’s Most Valuable Company Morningstar Canada

A cautionary tale that Europe can’t afford to ignore Fortune

Novo Nordisk (NOVOB) Loses Spot Among Europe’s 10 Most Valuable Firms Bloomberg

Northern lights: How a Nordic-Baltic coalition of the willing can do even more for Ukraine European Council on Foreign Relations (ECFR)

Novo Nordisk warns EU that new rules will push it to expand faster in US Financial Times

Ozempic shortages in EU will not affect all member states - Novo Nordisk Reuters

Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark Fortune

Denmark Is Hooked on Novo Nordisk's Success Bloomberg

How Novo Nordisk became Europe's most valuable company Yahoo Finance

After studies flag possible link between Novo's Ozempic and rare eye disorder, EU plans to investigate: Reuters Fierce Pharma

Novo Nordisk CEO questions alignment of Trump’s drug tariffs with EU-US trade deal Investing.com

Novo Nordisk briefly overtakes LVMH as Europe's most valuable company Reuters

Novo Nordisk A/S: Wegovy® recommended by the European GlobeNewswire

To see what European business could become, look to the Nordics The Economist

Novo Nordisk CEO sees new EU plan creating "uncertainty" and jeopardizing life science investments medwatch.com

Boss of Ozempic-maker Novo Nordisk steps down politico.eu

Novo Nordisk Seeks Approval For Higher Wegovy Dose In Europe Stocktwits

'Ozempidemic': How Novo Nordisk sells obesity awareness in Europe Euractiv

‘Very obvious:’ Novo Nordisk may be illegally advertising Ozempic, says Spain’s health secretary Euronews.com

EU, UK authorities crack down on fake versions of Novo Nordisk's Ozempic Fierce Pharma

EU backs use of Novo Nordisk's weight loss drug in adolescents Reuters

Novo Nordisk closes in on EU approval for its once-weekly insulin Awiqli Fierce Pharma

Wegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K. Fortune

Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market Reuters

The Ozempic boom: How the entire country of Denmark became a company town politico.eu

Novo Nordisk submits higher Wegovy dose for EU approval medwatch.com

Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company Financial Times

Novo Nordisk’s Ozempic faces EU review for potential eye disease connection Al Arabiya English

Novo Nordisk, Eli Lilly face scrutiny from EU's drug regulator over GLP-1 safety Fierce Pharma

Novo Nordisk ascent: Will Europe’s biggest company continue to soar? Euronews.com

Investors grab European equities to gain cheap US exposure Financial Times

Nordic Council’s international co-operation The Nordic Co-operation

Novo Nordisk files for EU approval of Ozempic in type II diabetes PharmaTimes

Novo Nordisk Archives Labiotech.eu

Nordisk Telemark 2 tent review TGO Magazine

PULSE-Project Selected as Promising Practice by the Eu Novo Nordisk Fonden

EU nod for Novo Nordisk’s Tresiba and Ryzodeg PMLiVE

Nordisk Mos down slippers review Snow Magazine